Palliative Care in Assisted Living
Mrs. M is a 92-year-old woman residing in an assisted living community. Her medical history includes hypertension, gout, hyperlipidemia, atrial fibrillation, hypothyroidism, and melanoma with invasion into the parotid gland; she has had removal of a lesion and a parotidectomy with nerve involvement impacting the 7th cranial nerve. Her medications include oral levothyroxine, 100 μg daily; oral vitamin D, 1,000 units daily; oral probenecid 500/colchicine, 0.5 mg daily; oral lisinopril, 5 mg daily; oral furosemide, 20 mg daily; oral duloxetine, 60 mg for depression; oral carvedilol, 6.25 mg twice a day; oral aspirin, 81 mg d...
Source: Caring for the Ages - March 29, 2022 Category: Health Management Authors: Barbara Resnick, Paige Hector Tags: Interdisciplinary Team Case Studies Source Type: news

Nonselective Beta-blockers and HCC Risk Among Cirrhotic Patients Nonselective Beta-blockers and HCC Risk Among Cirrhotic Patients
Might nonselective beta-blockers such as carvedilol, nadolol, and propranolol decrease the risk of hepatocellular carcinoma among patients with cirrhosis?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 6, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Dr Reddy's, Zydus Pharma recall products in US market
As per the report by the USFDA, Zydus Pharmaceuticals (USA) Inc, is recalling 2,880 bottles of Carvedilol tablets, USP 25 mg in the US due to, "presence of foreign tablets/ capsules; report of two Paroxetine tablets were found in the bottle." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 29, 2021 Category: Pharmaceuticals Source Type: news

Model May Help Predict Risk for Testing Positive for COVID - 19
Risk reduced with pneumococcal polysaccharide, flu vaccine; melatonin, paroxetine, or carvedilol use (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - June 25, 2020 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Critical Care, Emergency Medicine, Pathology, Pharmacy, Pulmonology, Journal, Source Type: news

Persistent wheezing caused by carvedilol overdose in a non-asthmatic man - Nakanishi M, Kuriyama A, Onodera M.
BACKGROUND: Cardiovascular dysfunction is the main manifestation of β-blocker intoxication; however, respiratory manifestations have rarely been reported. CASE PRESENTATION: A 41-year-old man, who had ingested 300 mg carvedilol in a suicide attempt, was ... (Source: SafetyLit)
Source: SafetyLit - February 3, 2020 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

WesternU College of Pharmacy Team Investigates Mechanisms for...
A research team from Western University of Health Sciences' College of Pharmacy is examining the potential for the beta-adrenergic receptor blocker carvedilol to prevent skin cancer. The...(PRWeb May 20, 2019)Read the full story at https://www.prweb.com/releases/westernu_college_of_pharmacy_team_investigates_mechanisms_for_carvedilol_to_prevent_skin_cancer/prweb16326198.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 20, 2019 Category: Pharmaceuticals Source Type: news

Lupin, Zydus Pharmaceuticals recall products in the US
Zydus Pharmaceuticals USA Inc, a subsidiary of Zydus Cadila, is also recalling 7,668 bottles of Carvedilol Tablets, used to treat high blood pressure, in the American market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 4, 2019 Category: Pharmaceuticals Source Type: news

Could Common Heart Meds Lower Prostate Cancer Risk?
The effect was found only with atenolol (Tenormin). Two other beta blockers -- metoprolol (Lopressor/Toprol XL) and carvedilol (Coreg) -- did not appear to provide any protection against prostate cancer. (Source: WebMD Health)
Source: WebMD Health - May 3, 2019 Category: Consumer Health News Source Type: news

Beta blockers: Do they cause weight gain?
Yes. Weight gain can occur as a side effect of some beta blockers, especially the older ones, such as atenolol (Tenormin) and metoprolol (Lopressor, Toprol-XL). The average weight gain is about 2.6 pounds (about 1.2 kilograms). Newer beta blockers, such as carvedilol (Coreg), don't usually cause weight gain as a side effect. Weight may rise [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 19, 2019 Category: Databases & Libraries Source Type: news

Is Cardiac Prophylaxis Effective in Early HER2+ Breast Cancer Patients?
In patients with HER2-positive breast cancer treated with anthracyclines plus trastuzumab, can adding lisinopril or carvedilol reduce the risk of cardiotoxicity? (Source: CancerNetwork)
Source: CancerNetwork - December 11, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

carvedilol (Coreg)
Title: carvedilol (Coreg)Category: MedicationsCreated: 1/16/2000 12:00:00 AMLast Editorial Review: 11/5/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 5, 2018 Category: Cardiology Source Type: news

carvedilol (Coreg, Coreg CR)
Title: carvedilol (Coreg, Coreg CR)Category: MedicationsCreated: 1/16/2000 12:00:00 AMLast Editorial Review: 9/12/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - September 12, 2018 Category: Cardiology Source Type: news

Carvedilol Helps Protect Heart During PPGL Surgery
(MedPage Today) -- Med offers superior blocking for cardiac complications in pheochromocytoma (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 23, 2018 Category: Cardiology Source Type: news

Teva Wins Reversal of U.S. Jury's $235 Mln GSK Drug Patent Verdict Teva Wins Reversal of U.S. Jury's $235 Mln GSK Drug Patent Verdict
A federal judge on Wednesday overturned a U.S. jury ' s verdict that required Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than $235 million for infringing a patent covering its blood pressure drug Coreg.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 29, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news